4.8 Article

Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Immunology

Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment

Jerome Custers et al.

Summary: This article reviews the safety and efficacy of Ad26 vector-based vaccines in clinical trials, showing good tolerability and immunogenicity in multiple studies. New developments in Ad26-based vaccines, including a COVID-19 vaccine currently in phase 3 clinical evaluation, are promising for vaccine development.

VACCINE (2021)

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Multidisciplinary Sciences

Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques

Noe B. Mercado et al.

NATURE (2020)

Article Multidisciplinary Sciences

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Mark J. Mulligan et al.

NATURE (2020)

Article Medicine, General & Internal

An mRNA Vaccine against SARS-CoV-2-Preliminary Report

L. A. Jackson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Biochemistry & Molecular Biology

Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters

Lisa H. Tostanoski et al.

NATURE MEDICINE (2020)